Known targets — ChEMBL curated mechanism
GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 6/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 5/20 | 0.34 |
| ▸ | CNR1 | P21554 | 3/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.33 |
| ▸ | PKLR | P30613 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isosulfan Blue Inner Salt SCHEMBL3324345 | 0.80 | MEN1 (0.44) | MEN1KMT2AALDH1A1L3MBTL1MAPT | |
| SCHEMBL340854 | 0.80 | MEN1 (0.44) | MEN1KMT2AALDH1A1L3MBTL1MAPT | |
| SCHEMBL126069 | 0.70 | THRB (0.47) | MEN1KMT2AALDH1A1MAPTCNR2 | |
| SCHEMBL341270 | 0.70 | THRB (0.45) | MEN1KMT2AALDH1A1MAPTCNR2 | |
| Sulfuric Acid SCHEMBL455054 | 0.70 | HSP90AA1 (0.51) | MEN1KMT2AALDH1A1L3MBTL1MAPT | |
| Sulfuric Acid SCHEMBL7234545 | 0.68 | MEN1 (0.49) | MEN1KMT2AALDH1A1L3MBTL1MAPT | |
| Ammonia Solution, Strong SCHEMBL1462578 | 0.66 | THRB (0.49) | MEN1KMT2AALDH1A1MAPTCNR2 | |
| SCHEMBL20740546 | 0.66 | THRB (0.48) | MEN1KMT2AALDH1A1MAPTCNR2 | |
| SCHEMBL124487 | 0.66 | THRB (0.50) | MEN1KMT2AALDH1A1MAPTCNR2 | |
| Hydrochloric Acid SCHEMBL1123567 | 0.66 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716527-A1 | A MULTIPLE UNIT ORAL DOSAGE FORM OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE FREE OF TITANIUM DIOXIDE | Italfarmaco SpA (IT) | 2026-04-01 | — | — | EP | disclosed |
| US-20250195439-A1 | METHOD FOR TREATING LOCAL LESION DISEASE | CHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD. (CN) | 2025-06-19 | — | — | US | disclosed |
| EP-3845247-B1 | USE OF AMINO ACID BASED NUTRIENTS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | CHENGDU KUACHANGAOPU MEDICAL TECH CO LTD (CN) | 2025-06-04 | — | — | EP | disclosed |
| EP-4305183-B1 | METHODS FOR DELIVERING A CARGO INTO A CELL | Trince bv (BE) | 2025-05-07 | — | — | EP | disclosed |
| WO-2024240747-A1 | A MULTIPLE UNIT ORAL DOSAGE FORM OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE FREE OF TITANIUM DIOXIDE | ITALFARMACO S.P.A. (IT) | 2024-11-28 | — | — | WO | disclosed |
| EP-4132905-B1 | PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS | PROVEPHARM LIFE SOLUTIONS (FR) | 2024-05-15 | — | — | EP | disclosed |
| EP-4132906-B1 | PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS | PROVEPHARM LIFE SOLUTIONS (FR) | 2024-05-15 | — | — | EP | disclosed |
| US-20240150794-A1 | Methods for Delivering a Cargo Into a Cell | Trince bv (BE) | 2024-05-09 | — | — | US | disclosed |
| EP-4361127-A2 | PROCESS FOR THE SYNTHESIS OF SULFONATED TRIARYLMETHANE COMPOUNDS | Provepharm Life Solutions (FR) | 2024-05-01 | — | — | EP | disclosed |
| EP-3691751-B1 | DUAL POLYMER COMPONENT HAIR COLORING COMPOSITION | WELLA OPERATIONS US LLC (US) | 2024-02-14 | — | — | EP | disclosed |
| WO-2007027132-A1 | TREATMENT OF INFLAMMATORY BOWEL DISEASE | ITH IMMUNE THERAPY HOLDINGS AB (SE) | 2007-03-08 | — | — | WO | disclosed |
| EP-1723222-A1 | BLEACH ACTIVATORS AND METHOD FOR THE PRODUCTION THEREOF | Henkel Kommanditgesellschaft auf Aktien (DE) | 2006-11-22 | — | — | EP | disclosed |
| CN-1842319-A | Dye composition and method for examining tooth demineralization damage | PROCTER & GAMBLE (US) | 2006-10-04 | — | — | CN | disclosed |
| EP-1655040-A1 | Contrast agent formulations for the visualization of the lymphatic system | Bracco Imaging, S.P.A. (IT) | 2006-05-10 | — | — | EP | disclosed |
| WO-2006037803-A1 | CONTRAST AGENT FORMULATIONS FOR THE VISUALIZATION OF THE LYMPHATIC SYSTEM | BRACCO IMAGING SPA (IT) | 2006-04-13 | — | — | WO | disclosed |
| US-20060002850-A1 | Radiolabeled lymphatic staining agents and methods for making | ISO-TEX DIAGNOSTICS, INC. | 2006-01-05 | — | — | US | disclosed |
| WO-2005087908-A1 | BLEACH ACTIVATORS AND METHOD FOR THE PRODUCTION THEREOF | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2005-09-22 | — | — | WO | disclosed |
| US-20050058602-A1 | Dye composition and method for detection of demineralized lesions in teeth | THE PROCTER & GAMBLE COMPANY | 2005-03-17 | — | — | US | disclosed |
| WO-2003089559-A1 | BLUE COLORED LIQUID CRYSTAL COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2003-10-30 | — | — | WO | disclosed |
| US-6475975-B1 | Blue colored liquid crystal compositions | COLGATE-PALMOLIVE COMPANY | 2002-11-05 | — | — | US | disclosed |